MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic

    S. El-Jaafary, M. Fabbri, T. de Lariestra, M. Matarazzo, B. Bergmans, M. Carecchio, R. Rajan, N. Vijiaratnam, H. Tibar, B. Bloem (Cairo, Egypt)

    Objective: To analyse the impact of the COVID-19 pandemic on the young MDS members assessing their satisfaction with the MDS virtual educational tools. Background: The…
  • MDS Virtual Congress 2021

    Is past use of statins associated with lower incidence of Parkinson’s disease?

    TTH. Nguyen, A. Fournier, F. Artaud, E. Courtois, S. Escolano, P. Tubert-Bitter, MC. Boutron, G. Severi, E. Roze, I. Degaey, M. Canonico, I. Ahmed, A. Thiébaut, A. Elbaz (Villejuif, France)

    Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…
  • MDS Virtual Congress 2021

    “I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

    P. Hobson, V. Adhiyaman (Rhyl, United Kingdom)

    Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…
  • MDS Virtual Congress 2021

    Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials

    G. Roussos, R. Bhatnagar, J. Burton, J. Cosman, A. Derungs, A. Dowling, K. Fisher, D. Hill, K. Praneeth Kilambi, L. Evers, N. Mehrotra, M. Minchik, M. Muller, T. Ruiz Herrero, S. Sardar, D. Stephenson (London, United Kingdom)

    Objective: The 3DT initiative of the Critical Path for Parkinson’s Consortium (CPP) aims to advance the regulatory maturity of digital biomarkers, for clinical studies in…
  • MDS Virtual Congress 2021

    Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson’s disease and motor fluctuations

    C. Carroll, A. Lees, J. Ferreira, M. Fonseca, D. Magalhaes, J. Rocha, P. Soares-da-Silva (Plymouth, United Kingdom)

    Objective: This post-hoc analysis evaluated the impact of 3-month earlier versus postponed initiation of opicapone (OPC) in patients with Parkinson’s disease (PD) and motor fluctuations.…
  • MDS Virtual Congress 2021

    Effects of Opicapone on Sleep in Patients with Parkinson’s Disease and Motor Fluctuations

    R. Hauser, A. Videnovic, P. Soares-da-Silva, G. Liang, K. Olson, E. Jen, JF. Rocha, O. Klepitskaya (Miami, USA)

    Objective: To assess the effects of opicapone (OPC: 50 mg, once-daily) on sleep in patients with Parkinson’s disease (PD) and motor fluctuations. Background: OPC is…
  • MDS Virtual Congress 2021

    A new fully implantable Adaptive Deep Brain Stimulation system tested for the first time in patients with Parkinson’s Disease

    T. Mandat, R. Eleopra, M. Lanotte, L. Lopiano, M. Yanssen, Y. Temel, E. Pirola, P. Rampini (Warsaw, Poland)

    Objective: This multicenter double-blind crossover study has been designed to evaluate the safety and efficacy of adaptive Deep Brain Stimulation delivered through an innovative IPG…
  • MDS Virtual Congress 2021

    The Impact of Visual Cueing on Gait Velocity in those with Parkinson’s Disease with Freezing of Gait

    M. Scavarda, K. Nagel, D. Peterson, K. Plesher, S. Moskowitz, C. Ivy, L. Denney (Phoenix, USA)

    Objective: To determine the ease of use and preliminary effectiveness of shoe-mounted visual cue (laser) on gait velocity in those with Parkinson’s Disease and freezing…
  • MDS Virtual Congress 2021

    The early post-transplant period in Parkinson’s disease: the low intravenous dose effect.

    V. Chyzhyk, V. Ponomarev, N. Aleinikava, A. Boika, M. Zafranskaya, D. Nizheharodava (Minsk, Belarus)

    Objective: To compare the early results of the introduction of MSCs via different routs of administration on the dynamics of the motor symptoms in patients…
  • MDS Virtual Congress 2021

    Evaluating a Novel Home-Based Care Pathway for People with Parkinson’s Disease

    E. King, J. Abraham, E. Edwards, T. Gorst, M. Holley, J. Inches, T. North, J. Rideout, S. Whipps, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the acceptability, feasibility, safety and effectiveness of a novel remotely delivered Parkinson’s care pathway. Background: Current care pathways for people with Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 422
  • 423
  • 424
  • 425
  • 426
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24475 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley